Nasopharyngeal Carcinoma: all 824 studies
Page 6 of 9. Open to participants first (281), then studies with results posted, then the rest; newest registration first within each.
- Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal CarcinomaStatus unknownNCT03915132Phase 2
- Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line TherapyCompletedNCT03906058Phase 2
- Tegio Consolidation Therapy for NPC Patients With High Risk of MetastasisStatus unknownNCT03904225Phase 2
- Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.Active, not recruitingNCT03891953Phase 1
- Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPCStatus unknownNCT03890185Phase 2
- Hepatic Artery Infusion Pump for NPC Liver MetastasesCompletedNCT03876574Phase 1
- A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal CarcinomaCompletedNCT03866967Phase 2
- Serial Epstein-Barr Virus DNA Surveillance in Nasopharyngeal Carcinoma PatientsActive, not recruitingNCT03855020
- IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.Status unknownNCT03854838Phase 2
- A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsCompletedNCT03849469Phase 1
- KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal CarcinomaCompletedNCT03848286Phase 2
- GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT03840421Phase 3
- Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma PatientsCompletedNCT03839602Phase 2
- Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal CarcinomaStatus unknownNCT03837808Phase 3
- Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal CarcinomaStatus unknownNCT03830996
- Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPCActive, not recruitingNCT03813394Phase 1/2
- 3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal CarcinomaCompletedNCT03810274
- Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck CancerTerminatedNCT03809624Phase 1
- 3DV+TPS Applied to Radiotherapy for Nasopharyngeal CarcinomaCompletedNCT03791944Not applicable
- Using Massage of Maxillofacial and Oral Cavity to Prevent Radioactive Oral MucositisCompletedNCT03788499Not applicable
- A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)CompletedNCT03752398Phase 1
- GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal CarcinomaStatus unknownNCT03723343
- Interleukin-11 Can Prevent and Treat of Radioactive Oral MucitisStatus unknownNCT03720340Phase 3
- Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaActive, not recruitingNCT03708822Phase 2
- Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT03707509Phase 3
- Demethylated Drug in the Treatment of Nasopharyngeal CarcinomaStatus unknownNCT03701451Phase 1/2
- Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal CarcinomaStatus unknownNCT03700476Phase 3
- Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion TherapyStatus unknownNCT03689556
- Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal CancerCompletedNCT03670342
- Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal CarcinomaStatus unknownNCT03668730Phase 2
- S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal CarcinomaCompletedNCT03668366Phase 2
- Nimotuzumab for Recurrent Nasopharyngeal CarcinomaStatus unknownNCT03666221Phase 2
- EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral DrugStatus unknownNCT03656965Phase 3
- Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRICompletedNCT03656250
- EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPCStatus unknownNCT03648697Phase 2
- Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined ChemotherapyStatus unknownNCT03647527
- Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal CarcinomaStatus unknownNCT03639467Phase 1/2
- PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal CarcinomaStatus unknownNCT03619824Phase 2
- Adjuvant Treatment of Apatinib in Nasopharyngeal CarcinomaStatus unknownNCT03612219Phase 2
- GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPCStatus unknownNCT03604965Phase 3
- Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal CarcinomaStatus unknownNCT03601975Phase 3
- Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPCCompletedNCT03601390
- Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal CarcinomaCompletedNCT03598218Not applicable
- TOMO Versus IMRT in Nasopharyngeal Carcinoma PatientsStatus unknownNCT03588403
- To Investigate the Molecular Mechanism of Traditional Chinese Medicine Constitution Using Next-generation Sequencing in Nasopharyngeal CarcinomaStatus unknownNCT03578575Phase 2
- TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPCStatus unknownNCT03574324Phase 3
- Radiation-associated Carotid Artery Disease in Patients With Nasopharyngeal CarcinomaStatus unknownNCT03568032
- By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPCStatus unknownNCT03557112Phase 2
- Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNATerminatedNCT03544099Phase 2
- Appaconitine Patch for Oral Mucositis Pain Caused by Chemoradiotherapy in Patients With Nasopharyngeal CancerStatus unknownNCT03518489Not applicable
- A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsCompletedNCT03517488Phase 1
- Dysphagia Assessment After Swallowing Sparing RadioTherapyCompletedNCT03448341
- PET and MRI in Prognosis Prediction of NPCCompletedNCT03429868Not applicable
- PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT03427827Phase 3
- Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal CarcinomaCompletedNCT03427359Phase 2
- Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma PatientsStatus unknownNCT03411954
- Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 StageStatus unknownNCT03403829Phase 3
- Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After RadiotherapyCompletedNCT03398980
- Nivolumab as Treatment for Recurrent/Metastatic Nasopharyngeal Carcinoma After Failing 2 Lines or More Previous ChemotherapyWithdrawnNCT03390738Phase 2
- Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal CarcinomaCompletedNCT03389295Phase 2
- A Prospective Study of Molecular Detection of Salvageable Early Recurrent Nasopharyngeal Carcinoma After RadiotherapyCompletedNCT03379610
- Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPCStatus unknownNCT03366415Phase 3
- To Study the Feasibility and Quality of Life of Medial Group Retropharyngeal Node Sparing in Nasopharyngeal CarcinomaStatus unknownNCT03346109Not applicable
- Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal CarcinomaStatus unknownNCT03344068Phase 2/3
- Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal CarcinomaActive, not recruitingNCT03321539Phase 3
- Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNACompletedNCT03314051
- TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal CarcinomaActive, not recruitingNCT03306121Phase 3
- Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma PatientsStatus unknownNCT03290820Phase 2
- The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma PatientsStatus unknownNCT03290001
- Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRTCompletedNCT03283293Phase 2
- Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT03282617Phase 1
- The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC PatientsCompletedNCT03240835
- Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)Status unknownNCT03213587Phase 2
- A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC.Status unknownNCT03210389Phase 2
- The Diagnosis of NPC Using the Probe-based Confocal Laser EndomicroscopyStatus unknownNCT03202173Not applicable
- the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal CancerStatus unknownNCT03196869Phase 2
- Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal CarcinomaCompletedNCT03180476Phase 2
- Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal CarcinomaCompletedNCT03177174Not applicable
- Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal CarcinomaCompletedNCT03175939Phase 2
- Maintenance Treatment of Apatinib in Nasopharyngeal CarcinomaStatus unknownNCT03130270Phase 2
- A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC SubjectsCompletedNCT03121716Phase 1
- Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal CarcinomaActive, not recruitingNCT03097939Phase 2
- Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal CarcinomaStatus unknownNCT03093649Not applicable
- Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal CarcinomaStatus unknownNCT03087695
- Atezolizumab and Bevacizumab in Treating Patients With Rare Solid TumorsActive, not recruitingNCT03074513Phase 2
- IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal CarcinomaStatus unknownNCT03068936Phase 3
- Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT03058432Phase 2
- Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal CancerTerminatedNCT03049358Not applicable
- Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal TissueStatus unknownNCT03048305
- Study of DC-CTL Combined With CIK for Advanced Solid TumorStatus unknownNCT03047525Phase 1/2
- Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT03047265Phase 2
- Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by ChemoradiotherapyStatus unknownNCT03045484Not applicable
- PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated MalignanciesStatus unknownNCT03044743Phase 1/2
- Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal CarcinomaCompletedNCT03025958Phase 2
- Prospective Study for Prognostic Biomarkers of Nasopharyngeal CarcinomaStatus unknownNCT03025854
- Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT03020329Phase 2
- Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal CarcinomaStatus unknownNCT03015727Phase 3
- High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal CancerCompletedNCT03007836Phase 1/2
- EUS-FNA for Retropharyngeal Lymph Node (RPLN) in Recurrent Nasopharyngeal Carcinoma (NPC) PatientsStatus unknownNCT03006588Phase 2/3
- A Study of Nasopharyngeal Carcinoma From GuangdongStatus unknownNCT03003182